Guardian Pharmacy Services (GRDN) Profitability Turn Reinforces Bullish Margin Narratives

Guardian Pharmacy Services (GRDN) has achieved consistent profitability in FY 2025, reporting Q4 revenue of US$397.6 million and EPS of US$0.33, with trailing 12-month net income shifting to a US$49.2 million profit. This turnaround in profitability and improving margins strengthen the bullish outlook for the company. While the stock trades at a P/E of 42.8x, slightly below peers but above the broader healthcare industry, forecast earnings growth of 16.5% and high-quality earnings fit an optimistic view, despite slower projected revenue growth of 4.7% per year.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments